TAG:
laboratory executive
Nine Key Trends Are Shaping Nation’s Healthcare Informatics
By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue
CEO SUMMARY: During the 1990s, hospital spending on information technology was devoted primarily to acquiring upgraded versions of software systems for clinical services such as laboratory, pharmacy, and radiology. That’s no longer true. As the following nine key trends in healthcare in…
Toronto Labs Stressed in Response To SARS Outbreak
By R. Lewis Dark | From the Volume X No. 5 – April 14, 2003 Issue
THIS ISSUE OF THE DARK REPORT BRINGS SOME OF THE FIRST DETAILS about how the SARS outbreak in the Canadian Province of Ontario is causing widespread, sustained disruption to hospitals, laboratories, and office-based physicians, particularly in the Toronto metropolitan area. When the earl…
Why Patient Safety Is Change Agent for Labs
By Robert Michel | From the Volume X No. 4 – March 24, 2003 Issue
CEO SUMMARY: In the 1990s, managed care was the dominant change agent to the nation’s healthcare system. During the 2000s, it will be patient safety. However, unlike the unpleasant consequences of HMOs, capitation, and utilization risk, patient safety will prove to be a benevolent trend…
Royal Free Hospital Is First Big British Lab Automation Project
By Robert Michel | From the Volume X No. 4 – March 24, 2003 Issue
CEO SUMMARY: To date, only a handful of total laboratory automation (TLA) projects have been implemented in Great Britain. One of those first TLA projects is at the Royal Free Hospital, Hampstead, located in the northern suburbs of London. Design work started in 1998 and the first phase b…
Needless Mastectomy Draws National Attention
By Robert Michel | From the Volume X No. 2 – February 10, 2003 Issue
CEO SUMMARY: This widely-reported case of misdiagnosis at an Allina hospital in St. Paul, Minnesota is a powerful reminder to pathology practices and clinical laboratories that breakdowns in medical quality will draw increasing attention and scrutiny. Both the patient and the community ar…
New Trends in 2003 Affect Clinical Lab Services
By Robert Michel | From the Volume X No. 1 – January 20, 2003 Issue
CEO SUMMARY: Here’s our current list of macro trends that affect clinical laboratories, updated from the last list in January 2000. One bold prediction is that Medicare, as we know it, is on the verge of a major meltdown. Employers and consumers are also new forces to be reckoned with b…
Laboratories Sit Squarely Between New Genetics and Today’s Medicine
By Robert Michel | From the Volume IX No. 18 – December 30, 2002 Issue
“Clinical laboratories and pathology groups are at the leading edge of the genetic revolution.” —Rick J. Carlson. CEO SUMMARY: Healthcare futurist Rick J. Carlson believes that knowledge of the human genome will trigger revolutionary…
Grasping the Impact of the Genetic Revolution
By R. Lewis Dark | From the Volume IX No. 18 – December 30, 2002 Issue
IT’S BEEN SEVEN MONTHS since healthcare futurist Rick J. Carlson shared his insights about the impending genomic/proteomic revolution at the Executive War College in NewnOrleans last May. A key theme of his message was that diagnostic services would be squarely in the middle of the coming genetics…
Non-Pathologists Altering U.S. Laboratory Industry
By Robert Michel | From the Volume IX No. 13 – September 16, 2002 Issue
CEO SUMMARY: It’s an interesting contradiction. On one hand, most pathologists enthusiastically recognize the value that diagnostic testing services provide to the healthcare community. On the other hand, too often it is non-laboratorians who provide the investment capital and entrepren…
Will “Free Testing” Ploy Financially Affect Labs?
By Robert Michel | From the Volume IX No. 12 – August 26, 2002 Issue
CEO SUMMARY: It’s a marketing scheme which public lab companies have quietly used for years. Now there is evidence that the use of “Waiver of Charges to Managed Care Patients” (free testing) seems to be on the increase, raising new questions about how and why competitive practices a…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized